Bruker Revenue Per Share Over Time
BRKR Stock | USD 57.39 0.39 0.68% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Bruker Performance and Bruker Correlation. Bruker |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bruker. If investors know Bruker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bruker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.55) | Dividend Share 0.2 | Earnings Share 2.07 | Revenue Per Share 21.982 | Quarterly Revenue Growth 0.164 |
The market value of Bruker is measured differently than its book value, which is the value of Bruker that is recorded on the company's balance sheet. Investors also form their own opinion of Bruker's value that differs from its market value or its book value, called intrinsic value, which is Bruker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bruker's market value can be influenced by many factors that don't directly affect Bruker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bruker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bruker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bruker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Revenue Per Share Analysis
Compare Bruker and related stocks such as Orthofix Medical, NuVasive, and Glaukos Corp Revenue Per Share Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OFIX | 2.3826 | 31.7788 | 24.3618 | 21.4221 | 21.7929 | 21.0952 | 22.5853 | 23.9451 | 24.4967 | 24.332 | 21.1005 | 23.5889 | 22.9741 | 20.3282 | 14.2 |
GKOS | 1.2231 | 1.2231 | 1.2231 | 0.8417 | 1.8319 | 4.1032 | 3.4742 | 4.632 | 5.179 | 6.3441 | 5.0556 | 6.3333 | 5.962 | 6.4979 | 3.43 |
ITGR | 22.7869 | 30.5662 | 30.5662 | 30.5662 | 30.5662 | 30.5662 | 37.8084 | 37.8084 | 38.5599 | 38.5599 | 32.6821 | 37.0102 | 41.54 | 47.9194 | 50.32 |
CNMD | 5.2693 | 25.6701 | 27.1065 | 27.298 | 26.8044 | 26.0069 | 27.4608 | 28.5047 | 30.5724 | 33.7192 | 30.176 | 34.6559 | 34.8027 | 40.5877 | 42.62 |
LIVN | 3.2376 | 7.8523 | 9.2132 | 10.3899 | 10.3899 | 11.0476 | 24.8445 | 21.0021 | 22.827 | 22.4245 | 19.2254 | 20.4491 | 19.1091 | 21.3861 | 22.46 |
IRTC | 12.0848 | 12.0848 | 12.0848 | 12.0848 | 1.4727 | 2.4471 | 12.1214 | 4.3535 | 6.1665 | 8.4918 | 9.554 | 11.0063 | 13.736 | 16.1387 | 16.95 |
ZBH | 4.4427 | 23.7303 | 25.5672 | 27.2606 | 27.6527 | 32.0053 | 38.4195 | 38.7524 | 38.9823 | 38.9186 | 33.9348 | 32.7291 | 33.1102 | 35.4298 | 17.79 |
BIO | 5.115 | 73.9727 | 73.1437 | 74.6062 | 75.3236 | 69.1921 | 70.2504 | 72.8428 | 76.7566 | 77.4607 | 85.5155 | 97.9701 | 94.0826 | 91.4534 | 96.03 |
AORT | 1.7486 | 4.3594 | 4.8844 | 5.2357 | 5.2829 | 5.2587 | 5.6625 | 5.7472 | 7.475 | 7.4417 | 6.6883 | 7.6658 | 7.8385 | 8.6887 | 9.12 |
AXGN | 1.692 | 1.3116 | 0.6936 | 0.8109 | 0.949 | 1.0481 | 1.3389 | 1.8134 | 2.2608 | 2.7198 | 2.8098 | 3.0901 | 3.2931 | 3.7084 | 2.3 |
LUNG | 0.966 | 0.966 | 0.966 | 0.966 | 0.966 | 0.966 | 0.966 | 0.966 | 0.966 | 0.9201 | 0.9171 | 1.3401 | 1.4465 | 1.8084 | 0.98 |
ELMD | 1.6096 | 2.4081 | 1.8615 | 1.9231 | 2.3915 | 2.8261 | 3.1661 | 3.4966 | 3.7682 | 3.8641 | 4.1741 | 4.9177 | 5.6792 | 6.3904 | 6.71 |
SRDX | 0.7872 | 2.9985 | 3.8808 | 4.2135 | 4.7508 | 5.4905 | 5.5586 | 6.2047 | 7.4746 | 7.6379 | 7.6379 | 7.1825 | 9.4494 | 8.9082 | 9.35 |
KIDS | 3.1835 | 3.1835 | 3.1835 | 3.1835 | 3.1835 | 4.1265 | 4.9642 | 9.4705 | 4.58 | 4.9611 | 3.9364 | 5.0886 | 5.9064 | 6.5592 | 4.22 |
FNA | 1.3916 | 1.3916 | 1.3916 | 1.3916 | 1.3916 | 1.3916 | 1.3916 | 1.3916 | 1.3916 | 1.3916 | 1.4531 | 1.929 | 2.3628 | 2.6361 | 1.56 |
Bruker and related stocks such as Orthofix Medical, NuVasive, and Glaukos Corp Revenue Per Share description
The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.My Equities
My Current Equities and Potential Positions
Bruker | BRKR |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Location | Massachusetts; U.S.A |
Exchange | NASDAQ Exchange |
USD 57.39
Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.